Global Preimplantation Genetic Testing Market is valued approximately USD 492.53 million in 2021 and is anticipated to grow with a healthy growth rate of more than 10.0% over the forecast period 2022-2028.
Pre-implantation genetic testing is the method that is used for the genetic analysis of embryos before implantation. It is a significant procedure because of rising cases of genetically imbalanced structures found in newborns and children. This method tests an embryo prior to implants for a particular, acknowledged genetic disorder. The increasing number of fertility clinics worldwide, technological advancements in the field of genetic analysis, and the growing public-private investments in the field of preimplantation genetic testing are the primary factors that are augmenting the market growth. In addition, the declining fertility rate, coupled with the rising incidences of chromosomal abnormalities with proceeding maternal age is the further factor that is surging the market demand across the globe. For instance, according to the World Bank, the fertility rate per total birth worldwide was accounted with 2.445 in 2016 and the amount is declined to 2.402 in 2019. Therefore, decreasing fertility rate is anticipated to fuels the preimplantation genetic testing demand, which, in turn, impels the market growth. However, the high procedural cost associated with preimplantation genetic testing and unfavorable government regulations impedes the growth of the market over the forecast period of 2022-2028. Also, growing awareness of assisted reproduction techniques and increasing medical tourism are anticipated to act as a catalyzing factor for the market demand during the estimated years.
The key regions considered for the global Preimplantation Genetic Testing market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the increasing adoption of genomic techniques and growing need for IVF procedures (with decreasing fertility rates). Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as rising developments in healthcare infrastructure, as well as the rising focus of leading players on emerging markets, would create lucrative growth prospects for the Preimplantation Genetic Testing market across the Asia-Pacific region.
Major market players included in this report are:
Illumina, Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
PerkinElmer, Inc.
CooperSurgical, Inc.
Beijing Genomics Institute (BGI)
Abbott Laboratories Inc.
Natera, Inc.
Good Start Genetics, Inc.
Yikon Genomics Co., Ltd.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product & Service:
Reagents & Consumables
Instruments
Software & Services
By Technology:
Next Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Fluorescent In-Situ Hybridization (FISH)
Comparative Genomic Hybridization (CGH)
Single Nucleotide Polymorphism (SNP)
By Procedure Type:
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis
By Application:
Aneuploidy
Structural Chromosomal Abnormalities
Single Gene Disorders
X-linked Disorders
HLA Typing
Gender Identification
By End User:
Maternity Centers & Fertility Clinics
Hospitals, Diagnostic Labs, and Service Providers
Research Laboratories & Academic Institutes
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Preimplantation Genetic Testing Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
- 1.2.1. Global Preimplantation Genetic Testing Market, by Region, 2020-2028 (USD Million)
- 1.2.2. Global Preimplantation Genetic Testing Market, by Product & Service, 2020-2028 (USD Million)
- 1.2.3. Global Preimplantation Genetic Testing Market, by Technology, 2020-2028 (USD Million)
- 1.2.4. Global Preimplantation Genetic Testing Market, by Procedure Type, 2020-2028 (USD Million)
- 1.2.5. Global Preimplantation Genetic Testing Market, by Application, 2020-2028 (USD Million)
- 1.2.6. Global Preimplantation Genetic Testing Market, by End User, 2020-2028 (USD Million)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Preimplantation Genetic Testing Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Preimplantation Genetic Testing Market Dynamics
- 3.1. Preimplantation Genetic Testing Market Impact Analysis (2020-2028)
- 3.1.1. Market Drivers
- 3.1.1.1. Rising public-private investments in the field of preimplantation genetic testing
- 3.1.1.2. Increasing number of fertility clinics globally
- 3.1.2. Market Challenges
- 3.1.2.1. High procedural cost associated with preimplantation genetic testing
- 3.1.2.2. Unfavourable government regulations
- 3.1.3. Market Opportunities
- 3.1.3.1. Growing awareness on assisted reproduction techniques
- 3.1.3.2. Increasing medical tourism
Chapter 4. Global Preimplantation Genetic Testing Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
- 4.2. PEST Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.3. Investment Adoption Model
- 4.4. Analyst Recommendation & Conclusion
- 4.5. Top investment opportunity
- 4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1.1. Assessment of the overall impact of COVID-19 on the industry
- 5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Preimplantation Genetic Testing Market, by Product & Service
- 6.1. Market Snapshot
- 6.2. Global Preimplantation Genetic Testing Market by Product & Service, Performance - Potential Analysis
- 6.3. Global Preimplantation Genetic Testing Market Estimates & Forecasts by Product & Service 2018-2028 (USD Million)
- 6.4. Preimplantation Genetic Testing Market, Sub Segment Analysis
- 6.4.1. Reagents & Consumables
- 6.4.2. Instruments
- 6.4.3. Software & Services
Chapter 7. Global Preimplantation Genetic Testing Market, by Technology
- 7.1. Market Snapshot
- 7.2. Global Preimplantation Genetic Testing Market by Technology, Performance - Potential Analysis
- 7.3. Global Preimplantation Genetic Testing Market Estimates & Forecasts by Technology 2018-2028 (USD Million)
- 7.4. Preimplantation Genetic Testing Market, Sub Segment Analysis
- 7.4.1. Next Generation Sequencing (NGS)
- 7.4.2. Polymerase Chain Reaction (PCR)
- 7.4.3. Fluorescent In-Situ Hybridization (FISH)
- 7.4.4. Comparative Genomic Hybridization (CGH)
- 7.4.5. Single Nucleotide Polymorphism (SNP)
Chapter 8. Global Preimplantation Genetic Testing Market, by Procedure Type
- 8.1. Market Snapshot
- 8.2. Global Preimplantation Genetic Testing Market by Procedure Type, Performance - Potential Analysis
- 8.3. Global Preimplantation Genetic Testing Market Estimates & Forecasts by Procedure Type 2018-2028 (USD Million)
- 8.4. Preimplantation Genetic Testing Market, Sub Segment Analysis
- 8.4.1. Preimplantation Genetic Screening
- 8.4.2. Preimplantation Genetic Diagnosis
Chapter 9. Global Preimplantation Genetic Testing Market, by Application
- 9.1. Market Snapshot
- 9.2. Global Preimplantation Genetic Testing Market by Application, Performance - Potential Analysis
- 9.3. Global Preimplantation Genetic Testing Market Estimates & Forecasts by Application 2018-2028 (USD Million)
- 9.4. Preimplantation Genetic Testing Market, Sub Segment Analysis
- 9.4.1. Aneuploidy
- 9.4.2. Structural Chromosomal Abnormalities
- 9.4.3. Single Gene Disorders
- 9.4.4. X-linked Disorders
- 9.4.5. HLA Typing
- 9.4.6. Gender Identification
Chapter 10. Global Preimplantation Genetic Testing Market, by End User
- 10.1. Market Snapshot
- 10.2. Global Preimplantation Genetic Testing Market by End User, Performance - Potential Analysis
- 10.3. Global Preimplantation Genetic Testing Market Estimates & Forecasts by End User 2018-2028 (USD Million)
- 10.4. Preimplantation Genetic Testing Market, Sub Segment Analysis
- 10.4.1. Maternity Centers & Fertility Clinics
- 10.4.2. Hospitals, Diagnostic Labs, and Service Providers
- 10.4.3. Research Laboratories & Academic Institutes
Chapter 11. Global Preimplantation Genetic Testing Market, Regional Analysis
- 11.1. Preimplantation Genetic Testing Market, Regional Market Snapshot
- 11.2. North America Preimplantation Genetic Testing Market
- 11.2.1. U.S. Preimplantation Genetic Testing Market
- 11.2.1.1. Product & Service estimates & forecasts, 2018-2028
- 11.2.1.2. Technology estimates & forecasts, 2018-2028
- 11.2.1.3. Procedure Type estimates & forecasts, 2018-2028
- 11.2.1.4. Application estimates & forecasts, 2018-2028
- 11.2.1.5. End User estimates & forecasts, 2018-2028
- 11.2.2. Canada Preimplantation Genetic Testing Market
- 11.3. Europe Preimplantation Genetic Testing Market Snapshot
- 11.3.1. U.K. Preimplantation Genetic Testing Market
- 11.3.2. Germany Preimplantation Genetic Testing Market
- 11.3.3. France Preimplantation Genetic Testing Market
- 11.3.4. Spain Preimplantation Genetic Testing Market
- 11.3.5. Italy Preimplantation Genetic Testing Market
- 11.3.6. Rest of Europe Preimplantation Genetic Testing Market
- 11.4. Asia-Pacific Preimplantation Genetic Testing Market Snapshot
- 11.4.1. China Preimplantation Genetic Testing Market
- 11.4.2. India Preimplantation Genetic Testing Market
- 11.4.3. Japan Preimplantation Genetic Testing Market
- 11.4.4. Australia Preimplantation Genetic Testing Market
- 11.4.5. South Korea Preimplantation Genetic Testing Market
- 11.4.6. Rest of Asia Pacific Preimplantation Genetic Testing Market
- 11.5. Latin America Preimplantation Genetic Testing Market Snapshot
- 11.5.1. Brazil Preimplantation Genetic Testing Market
- 11.5.2. Mexico Preimplantation Genetic Testing Market
- 11.6. Rest of The World Preimplantation Genetic Testing Market
Chapter 12. Competitive Intelligence
- 12.1. Top Market Strategies
- 12.2. Company Profiles
- 12.2.1. Illumina, Inc.
- 12.2.1.1. Key Information
- 12.2.1.2. Overview
- 12.2.1.3. Financial (Subject to Data Availability)
- 12.2.1.4. Product & Service Summary
- 12.2.1.5. Recent Developments
- 12.2.2. Thermo Fisher Scientific Inc.
- 12.2.3. Agilent Technologies, Inc.
- 12.2.4. PerkinElmer, Inc.
- 12.2.5. CooperSurgical, Inc.
- 12.2.6. Beijing Genomics Institute (BGI)
- 12.2.7. Abbott Laboratories Inc.
- 12.2.8. Natera, Inc.
- 12.2.9. Good Start Genetics, Inc.
- 12.2.10. Yikon Genomics Co., Ltd.
Chapter 13. Research Process
- 13.1. Research Process
- 13.1.1. Data Mining
- 13.1.2. Analysis
- 13.1.3. Market Estimation
- 13.1.4. Validation
- 13.1.5. Publishing
- 13.2. Research Attributes
- 13.3. Research Assumption